 | • レポートコード：QY2108PAL8904 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける臓器移植用免疫抑制剤の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、臓器移植用免疫抑制剤の種類別市場規模（タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他）、用途別市場規模（肝移植、腎臓移植、心臓移植、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の臓器移植用免疫抑制剤市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における臓器移植用免疫抑制剤の種類別市場規模（2016年-2027年）：タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他 ・世界における臓器移植用免疫抑制剤の用途別市場規模（2016年-2027年）：肝移植、腎臓移植、心臓移植、その他 ・臓器移植用免疫抑制剤の中国市場分析 - 臓器移植用免疫抑制剤の中国市場規模（2016年-2027年） - 中国における臓器移植用免疫抑制剤の主要プレイヤー別市場シェア - 中国における臓器移植用免疫抑制剤の種類別市場規模：タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他 - 中国における臓器移植用免疫抑制剤の用途別市場規模：肝移植、腎臓移植、心臓移植、その他 ・臓器移植用免疫抑制剤の北米市場（2016年-2027年） ・臓器移植用免疫抑制剤のヨーロッパ市場（2016年-2027年） ・臓器移植用免疫抑制剤のアジア太平洋市場（2016年-2027年） ・臓器移植用免疫抑制剤の中南米市場（2016年-2027年） ・臓器移植用免疫抑制剤の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Roche、Astellas Pharma Inc.、Huadong Pharmaceutical、Novartis、Catalent Pharma、Cinkate Corporation、Cilag、Genzyme、Changzhou Pharm、North China Pharmaceutical Group Corporation、SL PHARM、Livzon Pharmaceutical Group Inc., ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Immunosuppressants are a class of drugs that suppress the immune response through various mechanisms. In organ transplantation, immunosuppressants are used to prevent the body from either recognition or attacking the foreign organ via various immune responses. They should only be used under the supervision of appropriately trained and experienced staff.
In China, Organ Transplant Immunosuppressant key players include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, etc.
Market Analysis and Insights: Global and China Organ Transplant Immunosuppressant Market
This report focuses on global and China Organ Transplant Immunosuppressant market.
In 2020, the global Organ Transplant Immunosuppressant market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Organ Transplant Immunosuppressant market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Organ Transplant Immunosuppressant Scope and Market Size
Organ Transplant Immunosuppressant market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Organ Transplant Immunosuppressant market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others
Segment by Application
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Astellas Pharma Inc.
Huadong Pharmaceutical
Novartis
Catalent Pharma
Cinkate Corporation
Cilag
Genzyme
Changzhou Pharm
North China Pharmaceutical Group Corporation
SL PHARM
Livzon Pharmaceutical Group Inc.,
1 Study Coverage
1.1 Organ Transplant Immunosuppressant Product Introduction
1.2 Market by Type
1.2.1 Global Organ Transplant Immunosuppressant Market Size Growth Rate by Type
1.2.2 Tacrolimus
1.2.3 Mycophenolate Mofetil
1.2.4 Cyclosporin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Organ Transplant Immunosuppressant Market Size Growth Rate by Application
1.3.2 Liver Transplant
1.3.3 Kidney Transplant
1.3.4 Heart Transplant
1.3.5 Other Organ Transplant
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Organ Transplant Immunosuppressant Market Size, Estimates and Forecasts
2.1.1 Global Organ Transplant Immunosuppressant Revenue 2016-2027
2.1.2 Global Organ Transplant Immunosuppressant Sales 2016-2027
2.2 Global Organ Transplant Immunosuppressant, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Organ Transplant Immunosuppressant Historical Market Size by Region (2016-2021)
2.3.1 Global Organ Transplant Immunosuppressant Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Organ Transplant Immunosuppressant Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Organ Transplant Immunosuppressant Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Organ Transplant Immunosuppressant Sales Forecast by Region (2022-2027)
2.4.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Region (2022-2027)
3 Global Organ Transplant Immunosuppressant Competitor Landscape by Players
3.1 Global Top Organ Transplant Immunosuppressant Manufacturers by Sales
3.1.1 Global Organ Transplant Immunosuppressant Sales by Manufacturer (2016-2021)
3.1.2 Global Organ Transplant Immunosuppressant Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Organ Transplant Immunosuppressant Manufacturers by Revenue
3.2.1 Key Organ Transplant Immunosuppressant Manufacturers Covered: Ranking by Revenue
3.2.2 Global Organ Transplant Immunosuppressant Revenue by Manufacturers (2016-2021)
3.2.3 Global Organ Transplant Immunosuppressant Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Organ Transplant Immunosuppressant Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Organ Transplant Immunosuppressant Revenue in 2020
3.2.6 Global Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Organ Transplant Immunosuppressant Price by Manufacturers
3.4 Global Organ Transplant Immunosuppressant Manufacturing Base Distribution, Product Types
3.4.1 Organ Transplant Immunosuppressant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Organ Transplant Immunosuppressant Product Type
3.4.3 Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Organ Transplant Immunosuppressant Market Size by Type (2016-2021)
4.1.1 Global Organ Transplant Immunosuppressant Sales by Type (2016-2021)
4.1.2 Global Organ Transplant Immunosuppressant Revenue by Type (2016-2021)
4.1.3 Organ Transplant Immunosuppressant Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Organ Transplant Immunosuppressant Market Size Forecast by Type (2022-2027)
4.2.1 Global Organ Transplant Immunosuppressant Sales Forecast by Type (2022-2027)
4.2.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Type (2022-2027)
4.2.3 Organ Transplant Immunosuppressant Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Organ Transplant Immunosuppressant Market Size by Application (2016-2021)
5.1.1 Global Organ Transplant Immunosuppressant Sales by Application (2016-2021)
5.1.2 Global Organ Transplant Immunosuppressant Revenue by Application (2016-2021)
5.1.3 Organ Transplant Immunosuppressant Price by Application (2016-2021)
5.2 Organ Transplant Immunosuppressant Market Size Forecast by Application (2022-2027)
5.2.1 Global Organ Transplant Immunosuppressant Sales Forecast by Application (2022-2027)
5.2.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Application (2022-2027)
5.2.3 Global Organ Transplant Immunosuppressant Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Organ Transplant Immunosuppressant Market Size YoY Growth 2016-2027
6.1.1 China Organ Transplant Immunosuppressant Sales YoY Growth 2016-2027
6.1.2 China Organ Transplant Immunosuppressant Revenue YoY Growth 2016-2027
6.1.3 China Organ Transplant Immunosuppressant Market Share in Global Market 2016-2027
6.2 China Organ Transplant Immunosuppressant Market Size by Players (International and Local Players)
6.2.1 China Top Organ Transplant Immunosuppressant Players by Sales (2016-2021)
6.2.2 China Top Organ Transplant Immunosuppressant Players by Revenue (2016-2021)
6.3 China Organ Transplant Immunosuppressant Historic Market Review by Type (2016-2021)
6.3.1 China Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
6.3.2 China Organ Transplant Immunosuppressant Revenue Market Share by Type (2016-2021)
6.3.3 China Organ Transplant Immunosuppressant Price by Type (2016-2021)
6.4 China Organ Transplant Immunosuppressant Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Organ Transplant Immunosuppressant Sales Forecast by Type (2022-2027)
6.4.2 China Organ Transplant Immunosuppressant Revenue Forecast by Type (2022-2027)
6.4.3 China Organ Transplant Immunosuppressant Price Forecast by Type (2022-2027)
6.5 China Organ Transplant Immunosuppressant Historic Market Review by Application (2016-2021)
6.5.1 China Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
6.5.2 China Organ Transplant Immunosuppressant Revenue Market Share by Application (2016-2021)
6.5.3 China Organ Transplant Immunosuppressant Price by Application (2016-2021)
6.6 China Organ Transplant Immunosuppressant Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Organ Transplant Immunosuppressant Sales Forecast by Application (2022-2027)
6.6.2 China Organ Transplant Immunosuppressant Revenue Forecast by Application (2022-2027)
6.6.3 China Organ Transplant Immunosuppressant Price Forecast by Application (2022-2027)
7 North America
7.1 North America Organ Transplant Immunosuppressant Market Size YoY Growth 2016-2027
7.2 North America Organ Transplant Immunosuppressant Market Facts & Figures by Country
7.2.1 North America Organ Transplant Immunosuppressant Sales by Country (2016-2021)
7.2.2 North America Organ Transplant Immunosuppressant Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Organ Transplant Immunosuppressant Market Size YoY Growth 2016-2027
8.2 Asia Pacific Organ Transplant Immunosuppressant Market Facts & Figures by Region
8.2.1 Asia Pacific Organ Transplant Immunosuppressant Sales by Region (2016-2021)
8.2.2 Asia Pacific Organ Transplant Immunosuppressant Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Organ Transplant Immunosuppressant Market Size YoY Growth 2016-2027
9.2 Europe Organ Transplant Immunosuppressant Market Facts & Figures by Country
9.2.1 Europe Organ Transplant Immunosuppressant Sales by Country (2016-2021)
9.2.2 Europe Organ Transplant Immunosuppressant Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Organ Transplant Immunosuppressant Market Size YoY Growth 2016-2027
10.2 Latin America Organ Transplant Immunosuppressant Market Facts & Figures by Country
10.2.1 Latin America Organ Transplant Immunosuppressant Sales by Country (2016-2021)
10.2.2 Latin America Organ Transplant Immunosuppressant Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Organ Transplant Immunosuppressant Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Organ Transplant Immunosuppressant Market Facts & Figures by Country
11.2.1 Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2016-2021)
11.2.2 Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Organ Transplant Immunosuppressant Products Offered
12.1.5 Roche Recent Development
12.2 Astellas Pharma Inc.
12.2.1 Astellas Pharma Inc. Corporation Information
12.2.2 Astellas Pharma Inc. Description and Business Overview
12.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Products Offered
12.2.5 Astellas Pharma Inc. Recent Development
12.3 Huadong Pharmaceutical
12.3.1 Huadong Pharmaceutical Corporation Information
12.3.2 Huadong Pharmaceutical Description and Business Overview
12.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Products Offered
12.3.5 Huadong Pharmaceutical Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Organ Transplant Immunosuppressant Products Offered
12.4.5 Novartis Recent Development
12.5 Catalent Pharma
12.5.1 Catalent Pharma Corporation Information
12.5.2 Catalent Pharma Description and Business Overview
12.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Catalent Pharma Organ Transplant Immunosuppressant Products Offered
12.5.5 Catalent Pharma Recent Development
12.6 Cinkate Corporation
12.6.1 Cinkate Corporation Corporation Information
12.6.2 Cinkate Corporation Description and Business Overview
12.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Products Offered
12.6.5 Cinkate Corporation Recent Development
12.7 Cilag
12.7.1 Cilag Corporation Information
12.7.2 Cilag Description and Business Overview
12.7.3 Cilag Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Cilag Organ Transplant Immunosuppressant Products Offered
12.7.5 Cilag Recent Development
12.8 Genzyme
12.8.1 Genzyme Corporation Information
12.8.2 Genzyme Description and Business Overview
12.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Genzyme Organ Transplant Immunosuppressant Products Offered
12.8.5 Genzyme Recent Development
12.9 Changzhou Pharm
12.9.1 Changzhou Pharm Corporation Information
12.9.2 Changzhou Pharm Description and Business Overview
12.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Products Offered
12.9.5 Changzhou Pharm Recent Development
12.10 North China Pharmaceutical Group Corporation
12.10.1 North China Pharmaceutical Group Corporation Corporation Information
12.10.2 North China Pharmaceutical Group Corporation Description and Business Overview
12.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Products Offered
12.10.5 North China Pharmaceutical Group Corporation Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Organ Transplant Immunosuppressant Products Offered
12.11.5 Roche Recent Development
12.12 Livzon Pharmaceutical Group Inc.,
12.12.1 Livzon Pharmaceutical Group Inc., Corporation Information
12.12.2 Livzon Pharmaceutical Group Inc., Description and Business Overview
12.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Livzon Pharmaceutical Group Inc., Products Offered
12.12.5 Livzon Pharmaceutical Group Inc., Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Organ Transplant Immunosuppressant Industry Trends
13.2 Organ Transplant Immunosuppressant Market Drivers
13.3 Organ Transplant Immunosuppressant Market Challenges
13.4 Organ Transplant Immunosuppressant Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Organ Transplant Immunosuppressant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Organ Transplant Immunosuppressant Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tacrolimus
Table 3. Major Manufacturers of Mycophenolate Mofetil
Table 4. Major Manufacturers of Cyclosporin
Table 5. Major Manufacturers of Others
Table 6. Global Organ Transplant Immunosuppressant Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Organ Transplant Immunosuppressant Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Organ Transplant Immunosuppressant Sales by Regions (2016-2021) & (K Units)
Table 9. Global Organ Transplant Immunosuppressant Sales Market Share by Regions (2016-2021)
Table 10. Global Organ Transplant Immunosuppressant Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Organ Transplant Immunosuppressant Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Organ Transplant Immunosuppressant Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Organ Transplant Immunosuppressant Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Organ Transplant Immunosuppressant Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Organ Transplant Immunosuppressant Manufacturers by Revenue (US$ Million) in 2020
Table 18. Organ Transplant Immunosuppressant Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Organ Transplant Immunosuppressant Revenue Share by Manufacturers (2016-2021)
Table 20. Global Organ Transplant Immunosuppressant Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Organ Transplant Immunosuppressant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant as of 2020)
Table 22. Key Manufacturers Organ Transplant Immunosuppressant Price (2016-2021) (US$/Unit)
Table 23. Organ Transplant Immunosuppressant Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Organ Transplant Immunosuppressant Product Type
Table 25. Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Organ Transplant Immunosuppressant Sales by Type (2016-2021) (K Units)
Table 28. Global Organ Transplant Immunosuppressant Sales Share by Type (2016-2021)
Table 29. Global Organ Transplant Immunosuppressant Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Organ Transplant Immunosuppressant Revenue Share by Type (2016-2021)
Table 31. Organ Transplant Immunosuppressant Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 32. Global Organ Transplant Immunosuppressant Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Organ Transplant Immunosuppressant Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Organ Transplant Immunosuppressant Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Organ Transplant Immunosuppressant Sales by Application (2016-2021) (K Units)
Table 38. Global Organ Transplant Immunosuppressant Sales Share by Application (2016-2021)
Table 39. Global Organ Transplant Immunosuppressant Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Organ Transplant Immunosuppressant Revenue Share by Application (2016-2021)
Table 41. Organ Transplant Immunosuppressant Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 42. Global Organ Transplant Immunosuppressant Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Organ Transplant Immunosuppressant Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Organ Transplant Immunosuppressant Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 47. China Organ Transplant Immunosuppressant Sales (K Units) of Key Companies (2016-2021)
Table 48. China Organ Transplant Immunosuppressant Sales Share by Company (2016-2021)
Table 49. China Organ Transplant Immunosuppressant Revenue (US$ Million) by Company (2016-2021)
Table 50. China Organ Transplant Immunosuppressant Revenue Share by Company (2016-2021)
Table 51. China Organ Transplant Immunosuppressant Sales (K Units) by Type (2016-2021)
Table 52. China Organ Transplant Immunosuppressant Sales Share by Type (2016-2021)
Table 53. China Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Organ Transplant Immunosuppressant Price (US$/Unit) by Type (2016-2021)
Table 55. China Organ Transplant Immunosuppressant Sales (K Units) by Type (2022-2027)
Table 56. China Organ Transplant Immunosuppressant Sales Share by Type (2022-2027)
Table 57. China Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Organ Transplant Immunosuppressant Revenue Share by Type (2022-2027)
Table 59. China Organ Transplant Immunosuppressant Price (US$/Unit) by Type (2022-2027)
Table 60. China Organ Transplant Immunosuppressant Sales (K Units) by Application (2016-2021)
Table 61. China Organ Transplant Immunosuppressant Sales Share by Application (2016-2021)
Table 62. China Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Organ Transplant Immunosuppressant Price (US$/Unit) by Application (2016-2021)
Table 64. China Organ Transplant Immunosuppressant Sales (K Units) by Application (2022-2027)
Table 65. China Organ Transplant Immunosuppressant Sales Share by Application (2022-2027)
Table 66. China Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Organ Transplant Immunosuppressant Revenue Share by Application (2022-2027)
Table 68. China Organ Transplant Immunosuppressant Price (US$/Unit) by Application (2022-2027)
Table 69. North America Organ Transplant Immunosuppressant Sales by Country (2016-2021) & (K Units)
Table 70. North America Organ Transplant Immunosuppressant Sales Market Share by Country (2016-2021)
Table 71. North America Organ Transplant Immunosuppressant Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Organ Transplant Immunosuppressant Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Organ Transplant Immunosuppressant Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Organ Transplant Immunosuppressant Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Organ Transplant Immunosuppressant Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Organ Transplant Immunosuppressant Revenue Market Share by Region (2016-2021)
Table 77. Europe Organ Transplant Immunosuppressant Sales by Country (2016-2021) & (K Units)
Table 78. Europe Organ Transplant Immunosuppressant Sales Market Share by Country (2016-2021)
Table 79. Europe Organ Transplant Immunosuppressant Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Organ Transplant Immunosuppressant Revenue Market Share by Country (2016-2021)
Table 81. Latin America Organ Transplant Immunosuppressant Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Organ Transplant Immunosuppressant Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Organ Transplant Immunosuppressant Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Organ Transplant Immunosuppressant Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Country (2016-2021)
Table 89. Roche Corporation Information
Table 90. Roche Description and Business Overview
Table 91. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 92. Roche Organ Transplant Immunosuppressant Product
Table 93. Roche Recent Development
Table 94. Astellas Pharma Inc. Corporation Information
Table 95. Astellas Pharma Inc. Description and Business Overview
Table 96. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 97. Astellas Pharma Inc. Product
Table 98. Astellas Pharma Inc. Recent Development
Table 99. Huadong Pharmaceutical Corporation Information
Table 100. Huadong Pharmaceutical Description and Business Overview
Table 101. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 102. Huadong Pharmaceutical Product
Table 103. Huadong Pharmaceutical Recent Development
Table 104. Novartis Corporation Information
Table 105. Novartis Description and Business Overview
Table 106. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 107. Novartis Product
Table 108. Novartis Recent Development
Table 109. Catalent Pharma Corporation Information
Table 110. Catalent Pharma Description and Business Overview
Table 111. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 112. Catalent Pharma Product
Table 113. Catalent Pharma Recent Development
Table 114. Cinkate Corporation Corporation Information
Table 115. Cinkate Corporation Description and Business Overview
Table 116. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 117. Cinkate Corporation Product
Table 118. Cinkate Corporation Recent Development
Table 119. Cilag Corporation Information
Table 120. Cilag Description and Business Overview
Table 121. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 122. Cilag Product
Table 123. Cilag Recent Development
Table 124. Genzyme Corporation Information
Table 125. Genzyme Description and Business Overview
Table 126. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 127. Genzyme Product
Table 128. Genzyme Recent Development
Table 129. Changzhou Pharm Corporation Information
Table 130. Changzhou Pharm Description and Business Overview
Table 131. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 132. Changzhou Pharm Product
Table 133. Changzhou Pharm Recent Development
Table 134. North China Pharmaceutical Group Corporation Corporation Information
Table 135. North China Pharmaceutical Group Corporation Description and Business Overview
Table 136. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 137. North China Pharmaceutical Group Corporation Product
Table 138. North China Pharmaceutical Group Corporation Recent Development
Table 139. SL PHARM Corporation Information
Table 140. SL PHARM Description and Business Overview
Table 141. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 142. SL PHARM Product
Table 143. SL PHARM Recent Development
Table 144. Livzon Pharmaceutical Group Inc., Corporation Information
Table 145. Livzon Pharmaceutical Group Inc., Description and Business Overview
Table 146. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Livzon Pharmaceutical Group Inc., Product
Table 148. Livzon Pharmaceutical Group Inc., Recent Development
Table 149. Organ Transplant Immunosuppressant Market Trends
Table 150. Organ Transplant Immunosuppressant Market Drivers
Table 151. Organ Transplant Immunosuppressant Market Challenges
Table 152. Organ Transplant Immunosuppressant Market Restraints
Table 153. Organ Transplant Immunosuppressant Customers List
Table 154. Organ Transplant Immunosuppressant Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2020 & 2027
Figure 3. Tacrolimus Product Picture
Figure 4. Mycophenolate Mofetil Product Picture
Figure 5. Cyclosporin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Organ Transplant Immunosuppressant Sales Market Share by Application in 2020 & 2027
Figure 8. Liver Transplant
Figure 9. Kidney Transplant
Figure 10. Heart Transplant
Figure 11. Other Organ Transplant
Figure 12. Organ Transplant Immunosuppressant Report Years Considered
Figure 13. Global Organ Transplant Immunosuppressant Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Organ Transplant Immunosuppressant Market Size 2016-2027 (US$ Million)
Figure 15. Global Organ Transplant Immunosuppressant Sales 2016-2027 (K Units)
Figure 16. Global Organ Transplant Immunosuppressant Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2016-2021)
Figure 18. Global Organ Transplant Immunosuppressant Sales Market Share by Region in 2020
Figure 19. Global Organ Transplant Immunosuppressant Revenue Market Share by Region (2016-2021)
Figure 20. Global Organ Transplant Immunosuppressant Revenue Market Share by Region in 2020
Figure 21. Global Organ Transplant Immunosuppressant Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Organ Transplant Immunosuppressant Revenue in 2020
Figure 23. Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Organ Transplant Immunosuppressant Sales Market Share by Type (2016-2021)
Figure 25. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2020
Figure 26. Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2016-2021)
Figure 27. Global Organ Transplant Immunosuppressant Revenue Market Share by Type in 2020
Figure 28. Global Organ Transplant Immunosuppressant Sales Market Share by Application (2016-2021)
Figure 29. Global Organ Transplant Immunosuppressant Sales Market Share by Application in 2020
Figure 30. Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2016-2021)
Figure 31. Global Organ Transplant Immunosuppressant Revenue Market Share by Application in 2020
Figure 32. China Organ Transplant Immunosuppressant Sales Growth Rate 2016-2027 (K Units)
Figure 33. China Organ Transplant Immunosuppressant Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Organ Transplant Immunosuppressant Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Organ Transplant Immunosuppressant Players Market Share by Revenue in Organ Transplant Immunosuppressant in 2020
Figure 36. China Organ Transplant Immunosuppressant Revenue Share by Type (2016-2021)
Figure 37. China Organ Transplant Immunosuppressant Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Organ Transplant Immunosuppressant Revenue Share by Application (2016-2021)
Figure 39. China Organ Transplant Immunosuppressant Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Organ Transplant Immunosuppressant Sales Growth Rate 2016-2021 (K Units)
Figure 41. North America Organ Transplant Immunosuppressant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Organ Transplant Immunosuppressant Sales Market Share by Country in 2020
Figure 43. North America Organ Transplant Immunosuppressant Revenue Market Share by Country in 2020
Figure 44. U.S. Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 45. U.S. Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 47. Canada Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Organ Transplant Immunosuppressant Sales Growth Rate 2016-2021 (K Units)
Figure 49. Europe Organ Transplant Immunosuppressant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Organ Transplant Immunosuppressant Sales Market Share by Country in 2020
Figure 51. Europe Organ Transplant Immunosuppressant Revenue Market Share by Country in 2020
Figure 52. Germany Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 53. Germany Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 55. France Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 57. U.K. Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 59. Italy Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 61. Russia Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Organ Transplant Immunosuppressant Sales Growth Rate 2016-2021 (K Units)
Figure 63. Asia Pacific Organ Transplant Immunosuppressant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Organ Transplant Immunosuppressant Sales Market Share by Region in 2020
Figure 65. Asia Pacific Organ Transplant Immunosuppressant Revenue Market Share by Region in 2020
Figure 66. China Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 67. China Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 69. Japan Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 71. South Korea Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 73. India Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 75. Australia Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Taiwan Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 77. Taiwan Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 79. Indonesia Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 81. Thailand Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 83. Malaysia Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Philippines Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 85. Philippines Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Vietnam Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 87. Vietnam Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Latin America Organ Transplant Immunosuppressant Sales Growth Rate 2016-2021 (K Units)
Figure 89. Latin America Organ Transplant Immunosuppressant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 90. Latin America Organ Transplant Immunosuppressant Sales Market Share by Country in 2020
Figure 91. Latin America Organ Transplant Immunosuppressant Revenue Market Share by Country in 2020
Figure 92. Mexico Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 93. Mexico Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Brazil Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 95. Brazil Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Argentina Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 97. Argentina Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Middle East and Africa Organ Transplant Immunosuppressant Sales Growth Rate 2016-2021 (K Units)
Figure 99. Middle East and Africa Organ Transplant Immunosuppressant Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Country in 2020
Figure 101. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Country in 2020
Figure 102. Turkey Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 103. Turkey Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Saudi Arabia Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 105. Saudi Arabia Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. UAE Organ Transplant Immunosuppressant Sales Growth Rate (2016-2021) (K Units)
Figure 107. UAE Organ Transplant Immunosuppressant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Organ Transplant Immunosuppressant Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
臓器移植免疫抑制剤の世界市場 2020年 Market Overview The Organ Transplant Immunosuppressant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …- 腎臓移植拒絶治療の世界市場 2020年 Market Overview The global Kidney Transplant Rejection Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidn…
- 骨髄移植拒絶反応治療の世界市場 2020年 Market Overview The global Bone Marrow Transplant Rejection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bo…
- オルガンオンチップの世界市場 2020年 Market Overview The global Organ-on-a-Chip market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 38.2% in the forecast period of 2020 to 2025 and will expected to reach USD 109.6 million by 2025, from USD 30 million in 2019. The Organ-on-a-Chip market r…
- 頭皮用マイクロニードルの世界市場 2020年 Market Overview The global Scalp Microneedling market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Scalp Microneedling marke…